Trinity Biotech plc (TRIB)

Market Cap	16.44M
Revenue (ttm)	66.27M
Net Income (ttm)	-30.82M
Shares Out	38.21M
EPS (ttm)	-1.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	293,569
Open	0.380
Previous Close	0.376
Day's Range	0.380 - 0.560
52-Week Range	0.370 - 1.370
Beta	1.45
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 14, 2023

About TRIB

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, ru...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 398
• Stock Exchange: NASDAQ
• Ticker Symbol: TRIB